Novo Nordisk Fellowships
Novo Nordisk Postdoctoral Fellowship Programme at Karolinska Institutet
The fellowship programme were active 2015-2024 with the aims to support the development of a new generation of exceptional young diabetes and metabolism researchers, to become future leaders in the field, while further developing scientific excellence within these areas ultimately improving the lives of patients.
Overview
This academic-industry joint initiative has during its lifetime recruited 25 fellows receiving their postdoctoral training at 10 different Karolinska Institutet departments, working with 20 different research groups. Fellows have been undertaking cutting edge research projects, mentored by front-line researchers in the field of diabetes and metabolism. They have also had mentors at Novo Nordisk to support research collaborations with the company. Thus, Fellows have gained insight into research conducted in both academia and industry. In order to increase coherence around the Fellowship programme, a number of events have been held throughout the years such as high profile lectures, symposia, etc. both at Karolinska Institutet and at Novo Nordisk in the Copenhagen area.
Building Bridges: Diabetes and Metabolism Research at Karolinska Institutet and Novo Nordisk
Our final symposium was held on March 19-20, 2024 to celebrate the fellowship program active from 2015-2024. The meeting was a success and summarized the research and work performed in the program over the 10 years. In addition to scientific presentations, the program highlighted the fruitful collaborations between KI and Novo Nordisk and provided career information sessions. As such, the theme for the event was “building bridges”: building bridges to new people, to new environments, to new careers, to new knowledge, and to new treatments.
Building Bridges program
Previous KI-Novo Nordisk workshops/symposia:
With the aim to increase interactions between the company and Karolinska Institutet, there have been an additional 7 minisymposia organized by the fellowship program during 2016-2023 presenting research done by the fellows, investigators at KI as well as research and drug development performed by Novo Nordisk.
Alumni Fellows
Altogether 25 fellows were recruited from 18 different countries. The last fellows ended their fellowships end of 2024.
Dr Lars Paeger
Dr Noah Moruzzi
Dr Kelvin Kwok
Dr Thomas Ebert
Dr Ilke Sen
Dr Osman Ahmed
Programme Steering Committee
These members were active at the end of the programme.
Karolinska Institutet members
Prof. Juleen Zierath, Clinical Physiology. Steering Committee Chairman
Prof. Anders Gustafsson, Vice President of KI
Prof. Nancy Pedersen, Medical Epidemiology
Prof. Barbara Canlon, Hearing Physiology
Novo Nordisk members
Prof. Peter Kurtzhals, Chief Scientific Advisor, Novo Nordisk R&D
Prof. Daniel Brunicardi Timmermann, Head of Innovation, Global Drug Discovery
Contact
NovoNordiskFellowship@mmk.ki.se
Programme Manager